Bach Pharma Shareholder Update

September 2019

Corporate Newsletter

August - September 2019| Issue 1

Bach Pharma covered in over 150 News Outlets

In August, Bach Pharma created and released a Press Release that has been picked up and covered in over 150 new outlets around the world. The Press Release was designed to increase awareness of Bach Pharma Inc, GVT and our current fundraising efforts.

The press release, combined with the new Bach Pharma website and social media presence are designed to increase awareness of Bach Pharma and GVT to the general public, investors and the medical community.

View the Press Release Here .

Bach's Path to Success

Bach Pharma would like to congratulate our former intern, Paige Montanaro on her acceptance to Boston University's School of Medicine. Paige is the third Bach Pharma intern to be accepted into the program over the past couple of years. We want to wish Paige lots of luck and we know she'll be a huge success at BU!

BachPharma

is ONLINE

This Summer, Bach Pharma Inc. invested in updating our corporate Website, BachPharma.com in order to update and modernize our online presence. The new website is a work in progress, but the updates are instantly visible. Video, Images, Research Information, Informational Links and more make our website a better representation of Bach Pharma, GVT, our goals and our company.

Bach Pharma has also upgraded our Social Media presence in order to better reach and inform potential investors, clients, researchers and media.

Bach Pharma Twitter: HERE

Bach Pharma Facebook: HERE

Bach Pharma LinkedIn: HERE

Please follow, like and share Bach Pharma online.

$2.2M Phase I Fundraising efforts are Underway

Bach Pharma is in the midst of a $2.2M capital raise in order to fund the next stage of preclinical testing, specifically a toxicology study for the Veteran's Administration. Individual Investors, Foundations and Veteran Organizations have already committed over $500,000 to this project. Once the toxicology studies are completed, Bach will qualify for an additional $8 million commitment from the US Department of Defense for additional testing of GVT.

If you are interested in increasing your shares in Bach Pharma as part of this program, please reach out to Christopher LaFarge or Mark Henry for more information.

Our Corporate Management Team is Growing

Christopher G. LaFarge

Christopher LaFarge has more than 20 years of experience in managing and leading life science organizations. He has contributed to the development, testing, and approval of several medical devices as well as ISO 13485 certification for MedicaMetrix. Christopher served as President and CEO, and Chairman of MedicaMetrix, Inc., a medical device manufacturer in urology, and prior to this position, he was President at Pharos Medical, a medical device manufacturer in anesthesiology and patient monitoring.

Mr. LaFarge earned his BA in Biology from Harvard College, an MBA from the Yale School of Management, and an MFS (Environmental Science) from Yale University.

Bach is confident that his experience, knowledge, and education will contribute to bring Bach’s novel drug platform GVT® through clinical trials to FDA approval

If you are interested in investing or increasing your investment with Bach Pharma - reach out to Christopher directly, here.

Jamie Jamitkowski

Jamie Jamitkowski has worked in sales, marketing and corporate management for over 20 years. He is an entrepreneur who has started companies and grown companies quickly and exponentially.

Jamie earned his BS from Ithaca College and has a Masters in Management (MMH) from Cornell University.

Jamie joins Bach to spearhead our communications, presentations and marketing materials. Jamie and his team have already created multiple presentations and materials for our current $2.2M campaign. Additionally, his team has redeveloped the Bach Pharma website and social media platforms.

Lillian Puccia

Lily joined Bach Pharma as a recent graduate of the College of the Holy Cross in Worcester, MA.

Lily studied and has work experience in Social Media, Online Advertising, Marketing and Sales. While at Holy Cross, Lily wa s a 3 year starter for the NCAA Division 1 Holy Cross Soccer Team and a Senior Year Captain.

Lily has been an essential part of our Sales and Marketing Team, working with our Executive team on our marketing plans, strategies and materials.

Bach Pharma | BachPharma.com